DURECT Corp
DRRX1.910USD
0.000
종가 09/19, 16:00（ET）시세는 15분 지연됩니다
59.29M시가총액
손실P/E TTM
자세한 내용은 DURECT Corp 회사
DURECT Corporation is a late-stage biopharmaceutical company. The Company is engaged in the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Its lead drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in alcoholic hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which the FDA has granted a Fast Track and a Therapy designation, and metabolic dysfunction-associated steatohepatitis (MASH) is also being explored. Its commercial pharmaceutical product includes POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology. It has also completed Alcohol-Associated Hepatitis (AHFIRM) Phase 2b study.
회사 정보
종목 코드 DRRX
회사 이름DURECT Corp
상장일Sep 28, 2000
CEOMr. James E. Brown
직원 수21
유형Ordinary Share
회계 연도 종료Sep 28
주소10240 Bubb Road
도시CUPERTINO
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호95014
전화14087771417
웹사이트https://www.durect.com/
종목 코드 DRRX
상장일Sep 28, 2000
CEOMr. James E. Brown
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Ashley Robinson
Mr. Ashley Robinson
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Timothy M. Papp
Mr. Timothy M. Papp
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. James E. Brown
Mr. James E. Brown
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Norman L. Sussman, M.D.
Dr. Norman L. Sussman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Ashley Robinson
Mr. Ashley Robinson
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Timothy M. Papp
Mr. Timothy M. Papp
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. James E. Brown
Mr. James E. Brown
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Norman L. Sussman, M.D.
Dr. Norman L. Sussman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
데이터 없음
지역별USD
이름
수익
비율
Europe
172.00K
53.58%
United States
117.00K
36.45%
Other
32.00K
9.97%
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sun, Sep 14
마지막 업데이트: Sun, Sep 14
주주
주주 유형
주주
주주
비율
Asen (Scott R.)
10.31%
Richmond Brothers, Inc.
4.68%
Ingalls & Snyder LLC (Asset Management)
4.35%
The Vanguard Group, Inc.
4.08%
Dalton Investments, Inc.
2.40%
기타
74.18%
주주
주주
비율
Asen (Scott R.)
10.31%
Richmond Brothers, Inc.
4.68%
Ingalls & Snyder LLC (Asset Management)
4.35%
The Vanguard Group, Inc.
4.08%
Dalton Investments, Inc.
2.40%
기타
74.18%
주주 유형
주주
비율
Investment Advisor
12.88%
Individual Investor
11.00%
Investment Advisor/Hedge Fund
9.79%
Hedge Fund
0.60%
Research Firm
0.27%
Venture Capital
0.04%
기타
65.43%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
108
10.77M
34.70%
-3.79M
2025Q1
115
10.47M
33.77%
-4.69M
2024Q4
121
10.25M
33.03%
-6.31M
2024Q3
136
10.05M
32.37%
-5.85M
2024Q2
154
9.42M
30.55%
-4.23M
2024Q1
183
8.84M
28.67%
-5.03M
2023Q4
192
7.39M
25.17%
-5.35M
2023Q3
219
10.25M
37.42%
-1.75M
2023Q2
226
9.55M
39.01%
-2.60M
2023Q1
233
10.65M
43.65%
-399.75K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Asen (Scott R.)
3.08M
9.92%
+468.56K
+17.94%
Dec 31, 2024
Richmond Brothers, Inc.
1.35M
4.34%
+65.23K
+5.09%
Mar 31, 2025
Ingalls & Snyder LLC (Asset Management)
1.33M
4.3%
-256.06K
-16.10%
Mar 31, 2025
The Vanguard Group, Inc.
1.27M
4.08%
+128.60K
+11.29%
Mar 31, 2025
Dalton Investments, Inc.
512.31K
1.65%
+267.31K
+109.11%
Mar 31, 2025
Gagnon Securities LLC
403.88K
1.3%
+1.87K
+0.47%
Mar 31, 2025
Geode Capital Management, L.L.C.
333.33K
1.07%
+4.34K
+1.32%
Mar 31, 2025
Beirne Wealth Consulting Services, LLC
296.35K
0.95%
-29.52K
-9.06%
Mar 31, 2025
Montchanin Asset Management, LLC
310.12K
1%
+6.09K
+2.00%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
280.82K
0.9%
--
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Sep 6
마지막 업데이트: Sat, Sep 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Nov 28, 2022
Merger
10→1
Nov 28, 2022
Merger
10→1
Nov 28, 2022
Merger
10→1
Nov 28, 2022
Merger
10→1
날짜
유형
비율
Nov 28, 2022
Merger
10→1
Nov 28, 2022
Merger
10→1
Nov 28, 2022
Merger
10→1
Nov 28, 2022
Merger
10→1
